In osteosarcoma, CXCL8 promotes migration and activates Akt signaling to promote survival in vitro, and CXCL8 inhibition or knock down (KD) of the receptor CXCR1 decreases lung metastases in vivo (180–182). The gene discussed is CXCL8; the disease is osteosarcoma.